Compile Data Set for Download or QSAR
Report error Found 747 Enz. Inhib. hit(s) with Target = 'Phospholipase A2, membrane associated'
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740623(US20250154153, Compound 1218-40)
Affinity DataIC50: 0.120nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740621(US20250154153, Compound 1218-20S)
Affinity DataIC50: 0.141nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740628(US20250154153, Compound 1109-51)
Affinity DataIC50: 0.191nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740619(US20250154153, Compound 1218-39)
Affinity DataIC50: 0.191nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740622(US20250154153, Compound 1218-20R)
Affinity DataIC50: 0.209nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740620(US20250154153, Compound 1218-20)
Affinity DataIC50: 0.219nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740622(US20250154153, Compound 1218-20R)
Affinity DataIC50: 0.269nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740621(US20250154153, Compound 1218-20S)
Affinity DataIC50: 0.282nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740629(US20250154153, Compound 1109-52)
Affinity DataIC50: 0.282nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740632(US20250154153, Compound 1109-55S)
Affinity DataIC50: 0.288nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740620(US20250154153, Compound 1218-20)
Affinity DataIC50: 0.288nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740619(US20250154153, Compound 1218-39)
Affinity DataIC50: 0.398nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740627(US20250154153, Compound 1109-14)
Affinity DataIC50: 0.427nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740625(US20250154153, Compound 1218-4B)
Affinity DataIC50: 0.525nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740626(US20250154153, Compound 1109-15)
Affinity DataIC50: 0.603nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740624(US20250154153, Compound 1218-4A)
Affinity DataIC50: 0.617nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740626(US20250154153, Compound 1109-15)
Affinity DataIC50: 0.708nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740632(US20250154153, Compound 1109-55S)
Affinity DataIC50: 0.724nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740623(US20250154153, Compound 1218-40)
Affinity DataIC50: 0.794nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740630(US20250154153, Compound 1109-52S)
Affinity DataIC50: 1.07nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740628(US20250154153, Compound 1109-51)
Affinity DataIC50: 1.29nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50601469(CHEMBL5172164)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of human group IIA phospholipase A2 preincubated with compound for 10 mins followed by enzyme addition and measured after 30 mins by PC/DO...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740625(US20250154153, Compound 1218-4B)
Affinity DataIC50: 1.41nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740629(US20250154153, Compound 1109-52)
Affinity DataIC50: 1.51nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740624(US20250154153, Compound 1218-4A)
Affinity DataIC50: 1.82nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740631(US20250154153, Compound 1109-55)
Affinity DataIC50: 1.91nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740630(US20250154153, Compound 1109-52S)
Affinity DataIC50: 2.14nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740627(US20250154153, Compound 1109-14)
Affinity DataIC50: 2.29nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055371((3-aminooxalyl-1-biphenyl-2-ylmethyl-2-methyl-1H-i...)
Affinity DataIC50: 3nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through DOC/PC assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50161301(2-[4-(2-Benzenesulfonylamino-2-oxo-ethoxy)-1-benzy...)
Affinity DataIC50: 3nMAssay Description:Inhibitory concentration against human nonpancreatic secretory phospholipase A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50053137((1-Aminooxalyl-3-biphenyl-2-ylmethyl-2-ethyl-indol...)
Affinity DataIC50: 3nMAssay Description:Inhibition of human group IIA phospholipase A2 preincubated with compound for 10 mins followed by enzyme addition and measured after 30 mins by PC/DO...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055374([3-Aminooxalyl-1-(2-benzyl-benzyl)-2-ethyl-1H-indo...)
Affinity DataIC50: 4nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through DOC/PC assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055374([3-Aminooxalyl-1-(2-benzyl-benzyl)-2-ethyl-1H-indo...)
Affinity DataIC50: 4nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50161305((3-Aminooxalyl-1-cyclohexylmethyl-2-methyl-2,3-dih...)
Affinity DataIC50: 4nMAssay Description:Inhibitory concentration against human nonpancreatic secretory phospholipase A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50601472(CHEMBL5208632)
Affinity DataIC50: 5nMAssay Description:Inhibition of human group IIA phospholipase A2 preincubated with compound for 10 mins followed by enzyme addition and measured after 30 mins by PC/DO...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM740631(US20250154153, Compound 1109-55)
Affinity DataIC50: 5.37nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/16/2025
Entry Details
US Patent

TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50053137((1-Aminooxalyl-3-biphenyl-2-ylmethyl-2-ethyl-indol...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human group IIA phospholipase A2 incubated for 30 mins by automatic plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055401((3-Aminooxalyl-1-biphenyl-2-ylmethyl-2-ethyl-1H-in...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055371((3-aminooxalyl-1-biphenyl-2-ylmethyl-2-methyl-1H-i...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50161293((3-Aminooxalyl-1-benzyl-2-methyl-1,6,7,8-tetrahydr...)
Affinity DataIC50: 6nMAssay Description:Inhibitory concentration against human nonpancreatic secretory phospholipase A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055371((3-aminooxalyl-1-biphenyl-2-ylmethyl-2-methyl-1H-i...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human group IIA phospholipase A2 incubated for 1 hrs by scintillation counter analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055401((3-Aminooxalyl-1-biphenyl-2-ylmethyl-2-ethyl-1H-in...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through DOC/PC assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055379((3-Aminooxalyl-1-biphenyl-2-ylmethyl-2-cyclopropyl...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055378([3-Aminooxalyl-1-(2,6-dichloro-benzyl)-2-methyl-1H...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055387((R)-2-(3-Aminooxalyl-1-benzyl-2-methyl-1H-indol-4-...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through DOC/PC assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055366(Varespladib sodium | (3-Aminooxalyl-1-benzyl-2-eth...)
Affinity DataIC50: 7nMAssay Description:Inhibitory concentration against human nonpancreatic secretory phospholipase A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055366(Varespladib sodium | (3-Aminooxalyl-1-benzyl-2-eth...)
Affinity DataIC50: 7nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through DOC/PC assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50055367([3-Aminooxalyl-1-(3-chloro-benzyl)-2-ethyl-1H-indo...)
Affinity DataIC50: 7nMAssay Description:Inhibition of human nonpancreatic secretory Phospholipase A2 through chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50601470(CHEMBL5177527)
Affinity DataIC50: 7nMAssay Description:Inhibition of human group IIA phospholipase A2 incubated for 30 mins by automatic plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetPhospholipase A2, membrane associated(Human)
4B Technologies (Beijing)

US Patent
LigandPNGBDBM50601470(CHEMBL5177527)
Affinity DataIC50: 7nMAssay Description:Inhibition of human group IIA phospholipase A2 preincubated with compound for 10 mins followed by enzyme addition and measured after 30 mins by PC/DO...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
Displayed 1 to 50 (of 747 total ) | Next | Last >>
Jump to: